These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35665207)

  • 1. Mast cell-deficient mice
    Nsiah-Dosu S; Scholz C; Orinska Z; Sadik CD; Ludwig RJ; Schmidt E; Zillikens D; Hartmann K
    Skin Health Dis; 2022 Mar; 2(1):e70. PubMed ID: 35665207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.
    Chen R; Ning G; Zhao ML; Fleming MG; Diaz LA; Werb Z; Liu Z
    J Clin Invest; 2001 Oct; 108(8):1151-8. PubMed ID: 11602622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid.
    Heimbach L; Li Z; Berkowitz P; Zhao M; Li N; Rubenstein DS; Diaz LA; Liu Z
    J Biol Chem; 2011 Apr; 286(17):15003-9. PubMed ID: 21393236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation.
    Chen R; Fairley JA; Zhao ML; Giudice GJ; Zillikens D; Diaz LA; Liu Z
    J Immunol; 2002 Oct; 169(7):3987-92. PubMed ID: 12244200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.
    Fang H; Zhang Y; Li N; Wang G; Liu Z
    Front Immunol; 2018; 9():407. PubMed ID: 29545809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophils as putative therapeutic targets in bullous pemphigoid.
    Simon D; Borradori L; Simon HU
    Exp Dermatol; 2017 Dec; 26(12):1187-1192. PubMed ID: 28833620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of bullous pemphigoid.
    Kasperkiewicz M; Zillikens D
    Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):67-77. PubMed ID: 18094948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous pemphigoid (BP) patients with selective IgG autoreactivity against BP230: Review of a rare but valuable cohort with impact on the comprehension of the pathogenesis of BP.
    Ramcke T; Vicari E; Bolduan V; Enk A; Hadaschik E
    J Dermatol Sci; 2022 Feb; 105(2):72-79. PubMed ID: 34930674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita.
    Kasprick A; Yu X; Scholten J; Hartmann K; Pas HH; Zillikens D; Ludwig RJ; Petersen F
    Eur J Immunol; 2015 May; 45(5):1462-70. PubMed ID: 25678008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of FcRs in animal model of autoimmune bullous pemphigoid.
    Zhao M; Trimbeger ME; Li N; Diaz LA; Shapiro SD; Liu Z
    J Immunol; 2006 Sep; 177(5):3398-405. PubMed ID: 16920981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental animal models of bullous pemphigoid.
    Heimbach L; Li N; Diaz A; Liu Z
    G Ital Dermatol Venereol; 2009 Aug; 144(4):423-31. PubMed ID: 19755945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid.
    Lin L; Hwang BJ; Culton DA; Li N; Burette S; Koller BH; Messingham KA; Fairley JA; Lee JJ; Hall RP; An L; Diaz LA; Liu Z
    J Invest Dermatol; 2018 May; 138(5):1032-1043. PubMed ID: 29246800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement in experimental bullous pemphigoid.
    Liu Z; Giudice GJ; Swartz SJ; Fairley JA; Till GO; Troy JL; Diaz LA
    J Clin Invest; 1995 Apr; 95(4):1539-44. PubMed ID: 7706459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles for beta2 integrins in experimental autoimmune bullous pemphigoid.
    Liu Z; Zhao M; Li N; Diaz LA; Mayadas TN
    Blood; 2006 Feb; 107(3):1063-9. PubMed ID: 16234355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice.
    Fairley JA; Burnett CT; Fu CL; Larson DL; Fleming MG; Giudice GJ
    J Invest Dermatol; 2007 Nov; 127(11):2605-11. PubMed ID: 17611576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders.
    Didona D; Scarsella L; Fehresti M; Solimani F; Juratli HA; Göbel M; Mühlenbein S; Holiangu L; Pieper J; Korff V; Schmidt T; Sitaru C; Eming R; Hertl M; Pollmann R
    Front Immunol; 2021; 12():569287. PubMed ID: 33841390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants.
    Freire PC; Muñoz CH; Stingl G
    Br J Dermatol; 2017 Dec; 177(6):1644-1653. PubMed ID: 28868796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.
    Leighty L; Li N; Diaz LA; Liu Z
    Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.